Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma.
D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008535:Megestrol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D019290:Megestrol Acetate; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged
D008535:Megestrol; D019290:Megestrol Acetate